Financing the "Valley of Death" : an evaluation of incentive schemes for global health businesses
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2009. === Cataloged from PDF version of thesis. === Includes bibliographical references (p. 80-84). === Many early-stage biotech companies face a significant funding gap when trying to develop a new drug from preclinical developm...
Main Author: | Miller, Brian L. K |
---|---|
Other Authors: | Ernst R. Berndt and David Berry. |
Format: | Others |
Language: | English |
Published: |
Massachusetts Institute of Technology
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/1721.1/54591 |
Similar Items
-
Turning quicksand into bedrock : understanding the dynamic effects of disease-focused global health aid on health systems
by: Newkirk, Brian J
Published: (2010) -
The effects of licensing and equity financing cycles on pharmaceutical development
by: Alspaugh, Jonathan D. (Jonathan Douglas)
Published: (2012) -
The globalization of clinical drug development
by: Thiers, Fabio Albuquerque
Published: (2007) -
Using otoacoustic emissions to measure the transmission matrix of the middle-ear
by: Miller, Antonio John
Published: (2007) -
Brokering strategic partnerships between Asian and western biopharmaceutical companies in the global biologics market : assessment of capabilities of Asian participants in the biologics contract manufacturing organization marketplace
by: Chun, Soo Jin, S.M. Massachusetts Institute of Technology
Published: (2011)